Loading...
OTCM
VASO
Market cap30mUSD
Dec 05, Last price  
0.17USD
1D
11.16%
1Q
39.74%
Jan 2017
36.75%
Name

Vaso Corp

Chart & Performance

D1W1MN
OTCM:VASO chart
P/E
31.88
P/S
0.35
EPS
0.01
Div Yield, %
Shrs. gr., 5y
0.91%
Rev. gr., 5y
2.75%
Revenues
87m
+7.09%
15,095,77810,942,9976,354,0835,182,7684,471,1864,205,94216,373,42429,240,00032,890,00034,954,00057,082,00072,589,00072,788,00073,980,00075,746,00069,850,00075,579,00080,017,00081,024,00086,767,000
Net income
951k
-80.21%
-5,562,038-10,701,141-1,571,066-676,965-1,524,711-1,892,073-3,890,529-3,381,000-1,145,0001,128,0003,823,000820,000-4,539,000-3,734,00039,000358,0006,100,00011,873,0004,805,000951,000
CFO
3m
-38.05%
-4,594,584-2,275,873-1,233,294-32,021-1,716,860-1,588,3874,139,8409,431,000-1,504,0002,594,0006,520,0005,215,0001,599,000-1,453,000-1,333,0005,934,0007,815,00014,416,0005,296,0003,281,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
IPO date
Dec 01, 1988
Employees
272
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT